Literature DB >> 22395097

Historical overview of immunological tolerance.

Ronald H Schwartz1.   

Abstract

A fundamental property of the immune system is its ability to mediate self-defense with a minimal amount of collateral damage to the host. The system uses several different mechanisms to achieve this goal, which is collectively referred to as the "process of immunological tolerance." This article provides an introductory historical overview to these various mechanisms, which are discussed in greater detail throughout this collection, and then briefly describes what happens when this process fails, a state referred to as "autoimmunity."

Mesh:

Year:  2012        PMID: 22395097      PMCID: PMC3312674          DOI: 10.1101/cshperspect.a006908

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  173 in total

Review 1.  Systemic lupus erythematosus, complement deficiency, and apoptosis.

Authors:  M C Pickering; M Botto; P R Taylor; P J Lachmann; M J Walport
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

3.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 4.  How thymic antigen presenting cells sample the body's self-antigens.

Authors:  Jens Derbinski; Bruno Kyewski
Journal:  Curr Opin Immunol       Date:  2010-09-09       Impact factor: 7.486

Review 5.  Understanding crypticity is the key to revealing the pathogenesis of autoimmunity.

Authors:  Kamal D Moudgil; Eli E Sercarz
Journal:  Trends Immunol       Date:  2005-07       Impact factor: 16.687

6.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha.

Authors:  Yuanyuan Zha; Reinhard Marks; Allen W Ho; Amy C Peterson; Sujit Janardhan; Ian Brown; Kesavannair Praveen; Stacey Stang; James C Stone; Thomas F Gajewski
Journal:  Nat Immunol       Date:  2006-10-08       Impact factor: 25.606

8.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus.

Authors:  Deborah Smyth; Jason D Cooper; Joanne E Collins; Joanne M Heward; Jayne A Franklyn; Joanna M M Howson; Adrian Vella; Sarah Nutland; Helen E Rance; Lisa Maier; Bryan J Barratt; Cristian Guja; Constantin Ionescu-Tîrgoviste; David A Savage; David B Dunger; Barry Widmer; David P Strachan; Susan M Ring; Neil Walker; David G Clayton; Rebecca C J Twells; Stephen C L Gough; John A Todd
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

View more
  17 in total

1.  Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1.

Authors:  Lora Hamuro; Giridhar S Tirucherai; Sean M Crawford; Akbar Nayeem; Renuka C Pillutla; Binodh S DeSilva; Tarek A Leil; Craig J Thalhauser
Journal:  AAPS J       Date:  2019-07-24       Impact factor: 4.009

2.  PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome.

Authors:  Teresa Chuva; Frederick Pfister; Ortraud Beringer; Kerstin Felgentreff; Maike Büttner-Herold; Kerstin Amann
Journal:  Pediatr Nephrol       Date:  2017-05-09       Impact factor: 3.714

Review 3.  Perspectives on current controversial issues in the management of chronic HBV infection.

Authors:  Yun-Fan Liaw
Journal:  J Gastroenterol       Date:  2022-09-02       Impact factor: 6.772

4.  Construction and assessment of the immunogenicity and bactericidal activity of fusion protein porin A from Neisseria meningitidis serogroups A and B admixed with OMV adjuvant as a novel vaccine candidate.

Authors:  Parviz Afrough; Mohammad Reza Asadi Karam; Farzam Vaziri; Ava Behrouzi; Seyed Davar Siadat
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

Review 5.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 6.  A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy.

Authors:  Robert D Leone; Ying-Chun Lo; Jonathan D Powell
Journal:  Comput Struct Biotechnol J       Date:  2015-04-08       Impact factor: 7.271

7.  Preexisting Antibodies to an F(ab')2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment.

Authors:  Jane Ruppel; Ann Brady; Rebecca Elliott; Cecilia Leddy; Marco Palencia; Daniel Coleman; Jessica A Couch; Eric Wakshull
Journal:  J Immunol Res       Date:  2016-06-16       Impact factor: 4.818

Review 8.  PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.

Authors:  Jun Wang; Ruirong Yuan; Wenru Song; Jingwei Sun; Delong Liu; Zihai Li
Journal:  J Hematol Oncol       Date:  2017-01-25       Impact factor: 17.388

Review 9.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

Review 10.  Immune Mechanisms Linking Obesity and Preeclampsia.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Biomolecules       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.